Write on business with <a class="tweet-url username" href="https://twitter.com/workweekinc" data-screen-name="workweekinc" target="_blank" rel="nofollow">@workweekinc</a>. Building an AI research app: <a class="tweet-url username" href="https://twitter.com/bearlyai" data-screen-name="bearlyai" target="_blank" rel="nofollow">@bearlyai</a>

Trung Phan

By 2031, the market for obesity treatment drugs (aka GLP-1 agonists) will be >$150B. That is on a par with all drugs to treat cancer, which totalled $185bn in 2021 per The Economist. https://t.co/fXk5IeOMS4

GLP-1 drugs (like Ozempic) were originally made to treat diabetes but researchers found significant weight loss effects. Here some notes from the article: https://t.co/5WVwFaFGTC https://t.co/a8L69CWC2e

More technical details on the obesity treatments from Eric Topol: https://t.co/7IIehSCw2L https://t.co/1rQa1Jq3yq

Write on business. Create with @workweekinc. Co-host @niapodcast. Building an AI research app for reading + writing: https://t.co/fZ5ObIyBGI

from Trung Phan | by Trung Phan